MedCon: FDA officials say VIP is ‘win-win’ for agency and industry
Regulatory NewsJeff Craven
CDRHMedical DevicesProduct LifecycleUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsJeff CravenCDRHMedical DevicesProduct LifecycleUnited StatesUS Food and Drug Administration (FDA)